Emily Botnar
Analyst
H.C. Wainwright
Equibles does not estimate personal net worth.
About Emily Botnar
Emily Botnar is recorded as Analyst at H.C. Wainwright. Emily Botnar has spoken on 2 earnings calls and 1 other investor event across 2 companies, most recently for Agios Pharmaceuticals, Inc. on September 9, 2026. Those appearances were for Agios Pharmaceuticals, Inc. (AGIO) and Autolus Therapeutics plc (AUTL). The companies whose calls Emily Botnar spoke on are classified in the Healthcare sector.
Emily Botnar on recent calls
“Were any of the 2Q revenues driven by Europe specifically? And how do you kind of think about ex-U.S. revenue growth for the remainder of the year?”
“Were any of the 2Q revenues driven by Europe specifically? And how do you kind of think about ex-U.S. revenue growth for the remainder of the year?”
“Maybe a follow-up from the prior question. Can you kind of comment on what contribution UK revenue had on growth in the first quarter and how you're kind of expecting that to play out for the remainder of 2026?”
Affiliation history
-
H.C. Wainwright
Analyst
Transcript header (unverified)
Current